Eckert & Ziegler Strahlen- und Medizintechnik AG is a provider of isotope technology for medical, scientific, and industrial use. It operates through the following segments: Radiation Therapy, Isotope Products, Radiopharma, and Holding. The Radiation Therapy segment concentrates on product development, manufacturing, the market introduction, and the sale of radioactive products for cancer therapy. The Isotope Products segment manufactures and distributes standards and radiation sources for medical and industrial purposes. The Radiopharma segment comprises the device division for synthesis modules and accessories, short-lived radioactive agents imaging using positron emission tomography and longer-lived radioisotopes for pharmaceutical applications. The Holding segment refers to the holding company of the firm. The company was founded by Andreas Eckert in 1997 and is headquartered in Berlin, Germany.